GALDERMA LAB INC has a total of 40 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NOVAGALI PHARMA SA, UNIGEN PHARMACEUTICALS INC and LACCURE AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 22 | |
#2 | China | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Brazil | 2 | |
#5 | Republic of Korea | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Canada | 1 | |
#8 | Mexico | 1 | |
#9 | Norway | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Textiles and paper | |
#5 | Medical technology | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Dejovin Jack A | 14 |
#2 | Graeber Michael | 12 |
#3 | Leoni Matthew James | 11 |
#4 | Wagner Nathalie | 8 |
#5 | Dejovin Isabelle Jean | 8 |
#6 | Powala Christopher V | 6 |
#7 | Theobald Klaus | 5 |
#8 | Ashley Robert A | 5 |
#9 | Loesche Christian | 4 |
#10 | Freidenreich Philip | 3 |
Publication | Filing date | Title |
---|---|---|
US2011224215A1 | Pre-surgical treatment | |
MX2010002392A | Improved brimonidine compositions for treating erythema. | |
EP2182960A1 | Compounds, formulations, and methods for reducing skin wrinkles, creasing and sagging | |
US7439241B2 | Compounds, formulations, and methods for treating or preventing rosacea |